Automatized self-supervised learning for skin lesion screening.

Autor: Useini V; Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, 8092, Zurich, Switzerland.; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland., Tanadini-Lang S; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.; University of Zurich, Rämistrasse 71, 8006, Zurich, Switzerland., Lohmeyer Q; Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, 8092, Zurich, Switzerland., Meboldt M; Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, 8092, Zurich, Switzerland., Andratschke N; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.; University of Zurich, Rämistrasse 71, 8006, Zurich, Switzerland., Braun RP; Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091, Zurich, Switzerland., Barranco García J; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. javier.barrancogarcia@usz.ch.; University of Zurich, Rämistrasse 71, 8006, Zurich, Switzerland. javier.barrancogarcia@usz.ch.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2024 Jun 03; Vol. 14 (1), pp. 12697. Date of Electronic Publication: 2024 Jun 03.
DOI: 10.1038/s41598-024-61681-4
Abstrakt: Melanoma, the deadliest form of skin cancer, has seen a steady increase in incidence rates worldwide, posing a significant challenge to dermatologists. Early detection is crucial for improving patient survival rates. However, performing total body screening (TBS), i.e., identifying suspicious lesions or ugly ducklings (UDs) by visual inspection, can be challenging and often requires sound expertise in pigmented lesions. To assist users of varying expertise levels, an artificial intelligence (AI) decision support tool was developed. Our solution identifies and characterizes UDs from real-world wide-field patient images. It employs a state-of-the-art object detection algorithm to locate and isolate all skin lesions present in a patient's total body images. These lesions are then sorted based on their level of suspiciousness using a self-supervised AI approach, tailored to the specific context of the patient under examination. A clinical validation study was conducted to evaluate the tool's performance. The results demonstrated an average sensitivity of 95% for the top-10 AI-identified UDs on skin lesions selected by the majority of experts in pigmented skin lesions. The study also found that the tool increased dermatologists' confidence when formulating a diagnosis, and the average majority agreement with the top-10 AI-identified UDs reached 100% when assisted by our tool. With the development of this AI-based decision support tool, we aim to address the shortage of specialists, enable faster consultation times for patients, and demonstrate the impact and usability of AI-assisted screening. Future developments will include expanding the dataset to include histologically confirmed melanoma and validating the tool for additional body regions.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: